{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T22:10:42Z","timestamp":1790028642609,"version":"4.0.1"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Suzhou Science and Technology Bureau Foundation","award":["SZZCZJ202209"],"award-info":[{"award-number":["SZZCZJ202209"]}]},{"name":"Health Commission of Suzhou Foundation","award":["SZWJ2023a061"],"award-info":[{"award-number":["SZWJ2023a061"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Endocrinol Invest"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Papillary thyroid carcinoma (PTC) is the most common type of thyroid cancer. Despite the favorable prognosis in some patients, there remains a risk of lymph node metastasis and death in some patients. Therefore, new therapeutic strategies are required to improve PTC outcomes.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>In this study, we performed differential expression analysis using data from patients with PTC collected from the Cancer Genome Atlas program database, and prognostic analysis of differential genes. To understand the effects of ubiquitin-conjugating enzyme 9 (UBC9) on drug therapy, immunotherapy, immune relevance, and gene mutations in tumor cells of patients with PTC, we performed cancer drug susceptibility genomics, computed tumor immune dysfunction and exclusion, tertiary lymphoid tissues, cytolytic activity, immune infiltration, immune modulators, genomic signature differences, and gene ontology and Kyoto encyclopedia of genes and genomes enrichment analysis. Moreover, we investigated the function of UBC9 in tumor cells using a knockdown assay.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>UBC9 expression level was significantly elevated in the tumor tissues of patients with PTC, and in vitro experiments demonstrated that UBC9 knockdown inhibited tumor proliferation and migration and promoted apoptosis. UBC9 is closely linked to immunity in PTC, and UBC9 may be a potential therapeutic target.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>Our study demonstrated that UBC9 is a novel therapeutic target for PTC and may be a potential strategy for its treatment.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1007\/s40618-024-02523-y","type":"journal-article","created":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T04:39:15Z","timestamp":1740803955000},"page":"1101-1119","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["UBC9: a novel therapeutic target in papillary thyroid carcinoma"],"prefix":"10.1007","volume":"48","author":[{"given":"Hui","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingjing","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huaiyuan","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heng","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kemeng","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengxue","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4312-7832","authenticated-orcid":false,"given":"Genbao","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,1]]},"reference":[{"issue":"3","key":"2523_CR1","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, Jemal A (2024) Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 74(3):229\u2013263. https:\/\/doi.org\/10.3322\/caac.21834","journal-title":"CA Cancer J Clin"},{"issue":"5","key":"2523_CR2","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1001\/jama.2023.26348","volume":"331","author":"L Boucai","year":"2024","unstructured":"Boucai L, Zafereo M, Cabanillas ME (2024) Thyroid Cancer: a review. JAMA 331(5):425\u2013435. https:\/\/doi.org\/10.1001\/jama.2023.26348","journal-title":"JAMA"},{"issue":"1","key":"2523_CR3","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3322\/caac.21820","volume":"74","author":"RL Siegel","year":"2024","unstructured":"Siegel RL, Giaquinto AN, Jemal A (2024) Cancer statistics, 2024. CA Cancer J Clin 74(1):12\u201349. https:\/\/doi.org\/10.3322\/caac.21820","journal-title":"CA Cancer J Clin"},{"key":"2523_CR4","doi-asserted-by":"publisher","first-page":"1283397doi","DOI":"10.3389\/fendo.2023.1283397","volume":"14","author":"EM Volpi","year":"2023","unstructured":"Volpi EM, Ramirez-Ortega MC, Carrillo JF, Editorial (2023) Recent advances in papillary thyroid carcinoma: diagnosis and predictive factors. Front Endocrinol (Lausanne) 14:1283397doi. https:\/\/doi.org\/10.3389\/fendo.2023.1283397","journal-title":"Front Endocrinol (Lausanne)"},{"key":"2523_CR5","doi-asserted-by":"publisher","first-page":"102","DOI":"10.3389\/fendo.2020.00102","volume":"11","author":"A Prete","year":"2020","unstructured":"Prete A, Borges de Souza P, Censi S, Muzza M, Nucci N, Sponziello M (2020) Update on fundamental mechanisms of thyroid Cancer. Front Endocrinol (Lausanne) 11:102. https:\/\/doi.org\/10.3389\/fendo.2020.00102","journal-title":"Front Endocrinol (Lausanne)"},{"key":"2523_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.tcb.2024.01.002","author":"LA Claessens","year":"2024","unstructured":"Claessens LA, Vertegaal ACO (2024) SUMO proteases: from cellular functions to disease. Trends Cell Biol. https:\/\/doi.org\/10.1016\/j.tcb.2024.01.002","journal-title":"Trends Cell Biol"},{"issue":"11","key":"2523_CR7","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1038\/s41580-022-00500-y","volume":"23","author":"ACO Vertegaal","year":"2022","unstructured":"Vertegaal ACO (2022) Signalling mechanisms and cellular functions of SUMO. Nat Rev Mol Cell Biol 23(11):715\u2013731. https:\/\/doi.org\/10.1038\/s41580-022-00500-y","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"1","key":"2523_CR8","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1038\/s41467-023-44349-x","volume":"15","author":"Q Zhu","year":"2024","unstructured":"Zhu Q, Liang P, Meng H, Li F, Miao W, Chu C et al (2024) Stabilization of Pin1 by USP34 promotes Ubc9 isomerization and protein sumoylation in glioma stem cells. Nat Commun 15(1):40. https:\/\/doi.org\/10.1038\/s41467-023-44349-x","journal-title":"Nat Commun"},{"key":"2523_CR9","doi-asserted-by":"publisher","unstructured":"Xiao J, Sun F, Wang Y-N, Liu B, Zhou P, Wang F-X et al (2023) UBC9 deficiency enhances immunostimulatory macrophage activation and subsequent antitumor T cell response in prostate cancer. J Clin Invest 133(4). https:\/\/doi.org\/10.1172\/JCI158352","DOI":"10.1172\/JCI158352"},{"issue":"3","key":"2523_CR10","first-page":"676","volume":"159","author":"N Agrawal","year":"2014","unstructured":"Agrawal N, Akbani R, Aksoy BA, Ally A, Arachchi H, Asa SL et al (2014) Integr Genomic Charact Papillary Thyroid Carcinoma 159(3):676\u2013690","journal-title":"Integr Genomic Charact Papillary Thyroid Carcinoma"},{"issue":"260","key":"2523_CR11","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1080\/01621459.1952.10483441","volume":"47","author":"WH Kruskal","year":"1952","unstructured":"Kruskal WH, Wallis WAJJAA (1952) Use of ranks in one-criterion variance analysis. J Am Stat Assoc 47(260):583\u2013621","journal-title":"J Am Stat Assoc"},{"issue":"11","key":"2523_CR12","doi-asserted-by":"publisher","first-page":"1968","DOI":"10.1093\/bioinformatics\/bty920","volume":"35","author":"AA Rizvi","year":"2019","unstructured":"Rizvi AA, Karaesmen E, Morgan M, Preus L, Wang J, Sovic M, Hahn T, Sucheston-Campbell LE (2019) Gwasurvivr: an R package for genome-wide survival analysis. Bioinformatics 35(11):1968\u20131970. https:\/\/doi.org\/10.1093\/bioinformatics\/bty920","journal-title":"Bioinformatics"},{"issue":"7","key":"2523_CR13","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1002\/cac2.12067","volume":"40","author":"J Wu","year":"2020","unstructured":"Wu J, Zhang H, Li L, Hu M, Chen L, Xu B, Song Q (2020) A nomogram for predicting overall survival in patients with low-grade endometrial stromal sarcoma: a population-based analysis. Cancer Commun (Lond) 40(7):301\u2013312. https:\/\/doi.org\/10.1002\/cac2.12067","journal-title":"Cancer Commun (Lond)"},{"issue":"Database issue","key":"2523_CR14","doi-asserted-by":"publisher","first-page":"D955","DOI":"10.1093\/nar\/gks1111","volume":"41","author":"W Yang","year":"2013","unstructured":"Yang W, Soares J, Greninger P, Edelman EJ, Lightfoot H, Forbes S et al (2013) Genomics of Drug Sensitivity in Cancer (GDSC): a resource for therapeutic biomarker discovery in cancer cells. Nucleic Acids Res 41(Database issue):D955\u2013D961. https:\/\/doi.org\/10.1093\/nar\/gks1111","journal-title":"Nucleic Acids Res"},{"issue":"9","key":"2523_CR15","doi-asserted-by":"publisher","first-page":"e107468","DOI":"10.1371\/journal.pone.0107468","volume":"9","author":"P Geeleher","year":"2014","unstructured":"Geeleher P, Cox N, Huang RS (2014) pRRophetic: an R package for prediction of clinical chemotherapeutic response from tumor gene expression levels. PLoS ONE 9(9):e107468. https:\/\/doi.org\/10.1371\/journal.pone.0107468","journal-title":"PLoS ONE"},{"issue":"10","key":"2523_CR16","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.1038\/s41591-018-0136-1","volume":"24","author":"P Jiang","year":"2018","unstructured":"Jiang P, Gu S, Pan D, Fu J, Sahu A, Hu X et al (2018) Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response. Nat Med 24(10):1550\u20131558. https:\/\/doi.org\/10.1038\/s41591-018-0136-1","journal-title":"Nat Med"},{"key":"2523_CR17","doi-asserted-by":"publisher","first-page":"7doi","DOI":"10.1186\/1471-2105-14-7","volume":"14","author":"S H\u00e4nzelmann","year":"2013","unstructured":"H\u00e4nzelmann S, Castelo R, Guinney J (2013) GSVA: gene set variation analysis for microarray and RNA-seq data. BMC Bioinformatics 14:7doi. https:\/\/doi.org\/10.1186\/1471-2105-14-7","journal-title":"BMC Bioinformatics"},{"issue":"20","key":"2523_CR18","doi-asserted-by":"publisher","first-page":"4200","DOI":"10.1093\/bioinformatics\/btz210","volume":"35","author":"B Ru","year":"2019","unstructured":"Ru B, Wong CN, Tong Y, Zhong JY, Zhong SSW, Wu WC et al (2019) TISIDB: an integrated repository portal for tumor-immune system interactions. Bioinformatics 35(20):4200\u20134202. https:\/\/doi.org\/10.1093\/bioinformatics\/btz210","journal-title":"Bioinformatics"},{"issue":"7693","key":"2523_CR19","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1038\/nature25501","volume":"554","author":"S Mariathasan","year":"2018","unstructured":"Mariathasan S, Turley SJ, Nickles D, Castiglioni A, Yuen K, Wang Y et al (2018) TGF\u03b2 attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells. Nature 554(7693):544\u2013548. https:\/\/doi.org\/10.1038\/nature25501","journal-title":"Nature"},{"issue":"8","key":"2523_CR20","doi-asserted-by":"publisher","first-page":"e71","DOI":"10.1093\/nar\/gkv1507","volume":"44","author":"A Colaprico","year":"2016","unstructured":"Colaprico A, Silva TC, Olsen C, Garofano L, Cava C, Garolini D et al (2016) TCGAbiolinks: an R\/Bioconductor package for integrative analysis of TCGA data. Nucleic Acids Res 44(8):e71. https:\/\/doi.org\/10.1093\/nar\/gkv1507","journal-title":"Nucleic Acids Res"},{"issue":"4","key":"2523_CR21","doi-asserted-by":"publisher","first-page":"R41doi","DOI":"10.1186\/gb-2011-12-4-r41","volume":"12","author":"CH Mermel","year":"2011","unstructured":"Mermel CH, Schumacher SE, Hill B, Meyerson ML, Beroukhim R, Getz G (2011) GISTIC2.0 facilitates sensitive and confident localization of the targets of focal somatic copy-number alteration in human cancers. Genome Biol 12(4):R41doi. https:\/\/doi.org\/10.1186\/gb-2011-12-4-r41","journal-title":"Genome Biol"},{"issue":"7","key":"2523_CR22","doi-asserted-by":"publisher","first-page":"e47","DOI":"10.1093\/nar\/gkv007","volume":"43","author":"ME Ritchie","year":"2015","unstructured":"Ritchie ME, Phipson B, Wu D, Hu Y, Law CW, Shi W, Smyth GK (2015) Limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res 43(7):e47. https:\/\/doi.org\/10.1093\/nar\/gkv007","journal-title":"Nucleic Acids Res"},{"issue":"5","key":"2523_CR23","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1089\/omi.2011.0118","volume":"16","author":"G Yu","year":"2012","unstructured":"Yu G, Wang L-G, Han Y, He Q-Y (2012) clusterProfiler: an R package for comparing biological themes among gene clusters. OMICS 16(5):284\u2013287. https:\/\/doi.org\/10.1089\/omi.2011.0118","journal-title":"OMICS"},{"issue":"1","key":"2523_CR24","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1038\/75556","volume":"25","author":"M Ashburner","year":"2000","unstructured":"Ashburner M, Ball CA, Blake JA, Botstein D, Butler H, Cherry JM et al (2000) Gene ontology: tool for the unification of biology. The Gene Ontology Consortium. Nat Genet 25(1):25\u201329","journal-title":"Nat Genet"},{"issue":"1","key":"2523_CR25","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1093\/nar\/28.1.27","volume":"28","author":"M Kanehisa","year":"2000","unstructured":"Kanehisa M, Goto S (2000) KEGG: kyoto encyclopedia of genes and genomes. Nucleic Acids Res 28(1):27\u201330","journal-title":"Nucleic Acids Res"},{"key":"2523_CR26","doi-asserted-by":"publisher","unstructured":"McEligot AJ, Poynor V, Sharma R, Panangadan A (2020) Logistic LASSO regression for dietary intakes and breast Cancer. Nutrients 12(9). https:\/\/doi.org\/10.3390\/nu12092652","DOI":"10.3390\/nu12092652"},{"key":"2523_CR27","doi-asserted-by":"publisher","first-page":"215581doi","DOI":"10.1016\/j.canlet.2022.215581","volume":"532","author":"C Miro","year":"2022","unstructured":"Miro C, Di Giovanni A, Murolo M, Cicatiello AG, Nappi A, Sagliocchi S et al (2022) Thyroid hormone and androgen signals mutually interplay and enhance inflammation and tumorigenic activation of tumor microenvironment in prostate cancer. Cancer Lett 532:215581doi. https:\/\/doi.org\/10.1016\/j.canlet.2022.215581","journal-title":"Cancer Lett"},{"issue":"14","key":"2523_CR28","doi-asserted-by":"publisher","first-page":"1745","DOI":"10.1038\/onc.2014.115","volume":"34","author":"R Ferraldeschi","year":"2015","unstructured":"Ferraldeschi R, Welti J, Luo J, Attard G, de Bono JS (2015) Targeting the androgen receptor pathway in castration-resistant prostate cancer: progresses and prospects. Oncogene 34(14):1745\u20131757. https:\/\/doi.org\/10.1038\/onc.2014.115","journal-title":"Oncogene"},{"key":"2523_CR29","doi-asserted-by":"publisher","unstructured":"Jiaerken B, Liu W, Zheng J, Qu W, Wu Q, Ai Z (2024) The SUMO family: mechanisms and implications in thyroid Cancer pathogenesis and therapy. Biomedicines 12(10). https:\/\/doi.org\/10.3390\/biomedicines12102408","DOI":"10.3390\/biomedicines12102408"},{"issue":"3","key":"2523_CR30","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1530\/erc-19-0341","volume":"27","author":"T Williamson","year":"2020","unstructured":"Williamson T, Mendes TB, Joe N, Cerutti JM, Riggins GJ (2020) Mebendazole inhibits tumor growth and prevents lung metastasis in models of advanced thyroid cancer. Endocr Relat Cancer 27(3):123\u2013136. https:\/\/doi.org\/10.1530\/erc-19-0341","journal-title":"Endocr Relat Cancer"},{"issue":"3","key":"2523_CR31","doi-asserted-by":"publisher","first-page":"e1006262","DOI":"10.1371\/journal.ppat.1006262","volume":"13","author":"D Mattoscio","year":"2017","unstructured":"Mattoscio D, Casadio C, Miccolo C, Maffini F, Raimondi A, Tacchetti C et al (2017) Autophagy regulates UBC9 levels during viral-mediated tumorigenesis. PLoS Pathog 13(3):e1006262. https:\/\/doi.org\/10.1371\/journal.ppat.1006262","journal-title":"PLoS Pathog"},{"issue":"4","key":"2523_CR32","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1007\/s00125-017-4523-9","volume":"61","author":"X He","year":"2018","unstructured":"He X, Lai Q, Chen C, Li N, Sun F, Huang W et al (2018) Both conditional ablation and overexpression of E2 SUMO-conjugating enzyme (UBC9) in mouse pancreatic beta cells result in impaired beta cell function. Diabetologia 61(4):881\u2013895. https:\/\/doi.org\/10.1007\/s00125-017-4523-9","journal-title":"Diabetologia"},{"issue":"9","key":"2523_CR33","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1038\/s41388-022-02581-7","volume":"42","author":"T Wang","year":"2023","unstructured":"Wang T, Jin C, Yang P, Chen Z, Ji J, Sun Q et al (2023) UBE2J1 inhibits colorectal cancer progression by promoting ubiquitination and degradation of RPS3. Oncogene 42(9):651\u2013664. https:\/\/doi.org\/10.1038\/s41388-022-02581-7","journal-title":"Oncogene"},{"key":"2523_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/j.drudis.2020.09.015","author":"Y Zhou","year":"2020","unstructured":"Zhou Y, Chen R, Luo X, Zhang WD, Qin JJ (2020) The E2 ubiquitin-conjugating enzyme UbcH5c: an emerging target in cancer and immune disorders. Drug Discovery Today. https:\/\/doi.org\/10.1016\/j.drudis.2020.09.015","journal-title":"Drug Discovery Today"},{"issue":"1","key":"2523_CR35","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1186\/s12935-024-03323-3","volume":"24","author":"X Li","year":"2024","unstructured":"Li X, Ding Z, Tong Y (2024) Identification of SUMOylation-related biomarkers in papillary thyroid carcinoma. Cancer Cell Int 24(1):149. https:\/\/doi.org\/10.1186\/s12935-024-03323-3","journal-title":"Cancer Cell Int"},{"issue":"43","key":"2523_CR36","doi-asserted-by":"publisher","first-page":"6692","DOI":"10.1038\/s41388-020-01457-y","volume":"39","author":"I L\u00f3pez","year":"2020","unstructured":"L\u00f3pez I, Chalatsi E, Ellenbroek SIJ, Andrieux A, Roux P-F, Cerapio JP et al (2020) An unanticipated tumor-suppressive role of the SUMO pathway in the intestine unveiled by Ubc9 haploinsufficiency. Oncogene 39(43):6692\u20136703. https:\/\/doi.org\/10.1038\/s41388-020-01457-y","journal-title":"Oncogene"},{"issue":"5","key":"2523_CR37","doi-asserted-by":"publisher","first-page":"e31213","DOI":"10.1002\/jcp.31213","volume":"239","author":"Y-P Fan","year":"2024","unstructured":"Fan Y-P, Lou J-S, Jin M-R, Zhou C-H, Shen H-H, Fu C-Y et al (2024) UBC9-mediated SUMOylation of Lamin B1 enhances DNA-damage-induced nuclear DNA leakage and autophagy after spinal cord injury. J Cell Physiol 239(5):e31213. https:\/\/doi.org\/10.1002\/jcp.31213","journal-title":"J Cell Physiol"},{"issue":"6","key":"2523_CR38","doi-asserted-by":"publisher","first-page":"555","DOI":"10.3322\/caac.21802","volume":"73","author":"PJ Abraham","year":"2023","unstructured":"Abraham PJ, Wang R, Bahl D, Bhambhvani P, Ho S, Fazendin JM, Chen H, Lindeman BM (2023) Virtual Tumor Board: papillary thyroid carcinoma with nodal disease. CA Cancer J Clin 73(6):555\u2013561. https:\/\/doi.org\/10.3322\/caac.21802","journal-title":"CA Cancer J Clin"},{"issue":"8","key":"2523_CR39","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1016\/j.ccell.2021.07.009","volume":"39","author":"D Pe\u2019er","year":"2021","unstructured":"Pe\u2019er D, Ogawa S, Elhanani O, Keren L, Oliver TG (2021) Wedge DJCc. Tumor heterogeneity. Cancer Cell 39(8):1015\u20131017","journal-title":"Cancer Cell"},{"issue":"6","key":"2523_CR40","doi-asserted-by":"publisher","first-page":"3235","DOI":"10.1021\/acs.chemrev.1c00118","volume":"121","author":"N Kurt Yilmaz","year":"2021","unstructured":"Kurt Yilmaz N, Schiffer CA, Introduction (2021) Drug Resistance. Chem Rev 121(6):3235\u20133237. https:\/\/doi.org\/10.1021\/acs.chemrev.1c00118","journal-title":"Chem Rev"},{"issue":"15","key":"2523_CR41","doi-asserted-by":"publisher","first-page":"2770","DOI":"10.1016\/j.cell.2022.06.035","volume":"185","author":"MC Sellars","year":"2022","unstructured":"Sellars MC, Wu CJ, Fritsch EF (2022) Cancer vaccines: building a bridge over troubled waters. Cell 185(15):2770\u20132788. https:\/\/doi.org\/10.1016\/j.cell.2022.06.035","journal-title":"Cell"},{"key":"2523_CR42","doi-asserted-by":"publisher","first-page":"1573","DOI":"10.3389\/fimmu.2017.01573","volume":"8","author":"MY Bilal","year":"2017","unstructured":"Bilal MY, Dambaeva S, Kwak-Kim J, Gilman-Sachs A, Beaman KD (2017) A role for Iodide and Thyroglobulin in modulating the function of Human Immune cells. Front Immunol 8:1573. https:\/\/doi.org\/10.3389\/fimmu.2017.01573","journal-title":"Front Immunol"},{"key":"2523_CR43","doi-asserted-by":"publisher","first-page":"20254doi","DOI":"10.1038\/srep20254","volume":"6","author":"L Muller","year":"2016","unstructured":"Muller L, Mitsuhashi M, Simms P, Gooding WE, Whiteside TL (2016) Tumor-derived exosomes regulate expression of immune function-related genes in human T cell subsets. Sci Rep 6:20254doi. https:\/\/doi.org\/10.1038\/srep20254","journal-title":"Sci Rep"},{"issue":"6","key":"2523_CR44","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1016\/j.annonc.2024.03.007","volume":"35","author":"X Wang","year":"2024","unstructured":"Wang X, Lamberti G, Di Federico A, Alessi J, Ferrara R, Sholl ML, Awad MM, Vokes N, Ricciuti B (2024) Tumor mutational burden for the prediction of PD-(L)1 blockade efficacy in cancer: challenges and opportunities. Ann Oncol 35(6):508\u2013522. https:\/\/doi.org\/10.1016\/j.annonc.2024.03.007","journal-title":"Ann Oncol"},{"issue":"1","key":"2523_CR45","doi-asserted-by":"publisher","first-page":"101355doi","DOI":"10.1016\/j.xcrm.2023.101355","volume":"5","author":"S Cheng","year":"2024","unstructured":"Cheng S, Han Z, Dai D, Li F, Zhang X, Lu M et al (2024) Multi-omics of the gut microbial ecosystem in patients with microsatellite-instability-high gastrointestinal cancer resistant to immunotherapy. Cell Rep Med 5(1):101355doi. https:\/\/doi.org\/10.1016\/j.xcrm.2023.101355","journal-title":"Cell Rep Med"},{"key":"2523_CR46","doi-asserted-by":"publisher","first-page":"102886","DOI":"10.1016\/j.media.2023.102886","volume":"89","author":"K Kim","year":"2023","unstructured":"Kim K, Lee K, Cho S, Kang DU, Park S, Kang Y et al (2023) PAIP 2020: microsatellite instability prediction in colorectal cancer. Med Image Anal 89:102886. https:\/\/doi.org\/10.1016\/j.media.2023.102886","journal-title":"Med Image Anal"},{"key":"2523_CR47","doi-asserted-by":"publisher","unstructured":"Zhu M, Kim J, Deng Q, Ricciuti B, Alessi JV, Eglenen-Polat B et al (2023) Loss of p53 and mutational heterogeneity drives immune resistance in an autochthonous mouse lung cancer model with high tumor mutational burden. Cancer Cell 41(10). https:\/\/doi.org\/10.1016\/j.ccell.2023.09.006","DOI":"10.1016\/j.ccell.2023.09.006"}],"container-title":["Journal of Endocrinological Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-024-02523-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40618-024-02523-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-024-02523-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,3]],"date-time":"2025-05-03T05:50:35Z","timestamp":1746251435000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40618-024-02523-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,1]]},"references-count":47,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2025,5]]}},"alternative-id":["2523"],"URL":"https:\/\/doi.org\/10.1007\/s40618-024-02523-y","relation":{},"ISSN":["1720-8386"],"issn-type":[{"value":"1720-8386","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,1]]},"assertion":[{"value":"21 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 December 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study protocol was approved by the Anhui Wanbei Coal-Electricity Group General Hospital.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}